Choroid Plexus Neoplasms clinical trials
The registry lists 85 studies for Choroid Plexus Neoplasms across more than 10 countries. 2 are recruiting or about to start. 9 of them are mainly about Choroid Plexus Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.
Get an email when these change. Save the Choroid Plexus Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
National Cancer Institute (NCI) (18) · Pediatric Brain Tumor Consortium (12) · Children's Oncology Group (7) · Wake Forest University Health Sciences (5) · National Institutes of Health Clinical Center (CC) (5) · City of Hope Medical Center (3) · Children's Cancer and Leukaemia Group (3) · University of South Florida (3)
What is being tested here
Drugs under test in Choroid Plexus Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Temozolomide | 0 | 1 | 9 |
| Carboplatin | 0 | 2 | 9 |
| Cyclophosphamide | 0 | 1 | 4 |
| Etoposide | 0 | 0 | 4 |
| Irinotecan | 0 | 1 | 3 |
| Donepezil | 0 | 1 | 3 |
| O(6)-benzylguanine | 0 | 0 | 3 |
| Cisplatin | 0 | 1 | 3 |
| Thiotepa | 0 | 1 | 3 |
| Doxorubicin | 0 | 1 | 2 |
Drug classes tested here Alkylating agents 18 · Antimitotic agents 7 · HDAC inhibitors 4 · Tyrosine kinase inhibitors (TKIs) 3
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Mar 2027Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms · Jazz Pharmaceuticals
Who these studies take
Of the 1 Choroid Plexus Neoplasms studies recruiting now, 1 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 1 (100%) | 1 (100%) |
| 30 | 1 (100%) | 1 (100%) |
| 40 | 1 (100%) | 1 (100%) |
| 50 | 1 (100%) | 1 (100%) |
| 65 | 1 (100%) | 1 (100%) |
| 75 | 1 (100%) | 1 (100%) |
| 85 | 1 (100%) | 1 (100%) |
Across all 85 studies, recruiting or not: 71% stop at 75 or younger and 68% at 65; 71% take children; 0% are for women only and 1% for men only; 2% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 50 of 85. Browse all 85 → or search them.
- AI-Assisted MRI Molecular Subtyping in Pediatric Brain TumorsNot yet recruitingNCT07703605
- Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO ClassificationRecruitingNCT0525960512 countries
- Rare CNS Tumors Outcomes &RiskCompletedNCT032519891 country
- Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System NeoplasmsActive, not recruitingNCT04541082Phase 11 country
- Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid TumorsTerminatedNCT00788125Phase 1/21 country
- Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS CancersTerminatedNCT03173950Phase 21 country
- Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or EpendymomaActive, not recruitingNCT00602667Phase 22 countries
- Molecular-Guided Therapy for Childhood CancerCompletedNCT02162732Not applicable2 countries
- Study of Stored Tumor Samples in Young Patients With Brain TumorsTerminatedNCT008972861 country
- Liposomal Doxorubicin in Treating Children With Refractory Solid TumorsCompletedNCT00019630Phase 11 country
- Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid TumorsCompletedNCT00138216Phase 12 countries
- Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain TumorsCompletedNCT00369785Phase 31 country
- Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain TumorCompletedNCT00070161Phase 21 country
- Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic ChemotherapyCompletedNCT01346267Not applicable2 countries
- Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System TumorsTerminatedNCT02255461Phase 11 country
- Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With CancerTerminatedNCT01987596Phase 31 country
- Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain DisordersCompletedNCT002556711 country
- Treatment of Tumors of the Choroid Plexus EpitheliumTerminatedNCT00500890Phase 31 country
- Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid TumorsCompletedNCT00007813Phase 11 country
- Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus TumorsTerminatedNCT01014767Phase 34 countries
- Donepezil in Treating Young Patients With Primary Brain Tumors Previously Treated With Radiation Therapy to the BrainCompletedNCT00452868Early Phase 11 country
- Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain TumorsCompletedNCT009197506 countries
- Yoga Therapy in Treating Patients With Malignant Brain TumorsTerminatedNCT01234805Not applicable1 country
- A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain TumorsCompletedNCT00784914Phase 11 country
- p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System TumorsCompletedNCT01975116Phase 11 country
- Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain TumorsCompletedNCT004997981 country
- Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain TumorsWithdrawnNCT02194452Not applicable1 country
- Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain MetastasesTerminatedNCT02967380Not applicable1 country
- Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain TumorWithdrawnNCT00003273Phase 23 countries
- Study of Tissue Samples From Patients With Glioma or Other Brain TumorsCompletedNCT009672001 country
- Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical TrialCompletedNCT00890435
- RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant GliomaCompletedNCT01119599Phase 11 country
- Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for CancerTerminatedNCT01132547Phase 31 country
- Temozolomide and O6-benzylguanine in Treating Children With Solid TumorsCompletedNCT00020150Phase 11 country
- Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell LeukemiaTerminatedNCT01088763Phase 12 countries
- Metabolic Syndrome in Childhood Cancer SurvivorsCompletedNCT009207381 country
- Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to TreatmentWithdrawnNCT00458744Phase 1
- ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS TumorsCompletedNCT00946335Phase 11 country
- Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck CancerCompletedNCT00492089Phase 21 country
- Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord TumorsCompletedNCT00003141Phase 13 countries
- Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainCompletedNCT00538850Phase 31 country
- Development of Strategies to Increase Enrollment in Clinical Trials for Children With CancerCompletedNCT000024854 countries
- Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer TreatmentCompletedNCT00066248Phase 23 countries
- Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00008086Phase 11 country
- Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain TumorsStatus unknownNCT00392886Phase 35 countries
- Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS TumorsCompletedNCT00100880Phase 11 country
- Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain TumorsCompletedNCT00052780Phase 11 country
- Cilengitide in Treating Children With Refractory Primary Brain TumorsCompletedNCT00063973Phase 11 country
- Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem GliomaStatus unknownNCT00360854Phase 12 countries
- Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain TumorsStatus unknownNCT00002647Phase 11 country